AzTrials
AzTrials

Non-communicable DiseasesNCT04961073

Prevalence of Multiple Risk Behaviours and Its Association With Health Consequence

An observational study of Non-communicable Diseases, run by The University of Hong Kong at 1 site in Hong Kong.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Hong Kong is facing an increasing threat of non-communicable diseases (NCDs), which is compounded by population aging. In 2016, 25,771 registered deaths (approximately 55%) were attributed to NCDs. In addition, NCDs caused 104,600 potential years of life lost before 70 years of age. Read more about this study

Who is it for?
Ages 30 years and olderHealthy volunteers can take part
Conditions the study is for
Non-communicable Diseases
How many people
5,737 participants
Where
1 siteHong Kong
Study dates
21 Jun 2021to 31 Aug 2021
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 30 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Study population: A randomized sample of Hong Kong Chinese adults who aged 30 years or above will be recruited at hotspots in eighteen districts in Hong Kong.

Who may be able to join

  • Aged 30 years or above
  • Able to speak Cantonese

Who cannot join

  • Unable to speak Cantonese

Trial locations and contacts

1 site in 1 country.

Hong Kong1 site
  • The University of Hong Kong

    Hong Kong

Other trials in Hong Kong

About this study

Official title: The Prevalence of Multiple Risk Behaviours and Its Association With Health Consequence Among Hong Kong Chinese Adults

Hong Kong is facing an increasing threat of non-communicable diseases (NCDs), which is compounded by population aging. In 2016, 25,771 registered deaths (approximately 55%) were attributed to NCDs. In addition, NCDs caused 104,600 potential years of life lost before 70 years of age. WHO has identified four major behavioral risk factors - tobacco use, harmful use of alcohol, an unhealthy diet, and physical inactivity - that contribute substantially to NCDs and can increase the risk of death. Most premature deaths from NCDs are preventable via lifestyle modification. Therefore, helping people adopting healthy lifestyle practices, such as having a balanced diet and engaging in irregular physical activity, and quitting health-risk behaviors, such as smoking and harmful use of alcohol can help prevent NCDs and improve the quality of life and overall health of the population. However, many people are unmotivated or find it difficult to modify their risk behaviors, despite their awareness of the associated health hazards.

Read the detailed description

Non-communicable diseases (NCDs), including cardiovascular diseases, cancers, diabetes and chronic respiratory diseases, are the most common and preventable causes of morbidity and mortality both globally and locally. According to the World Health Organization (WHO), 41 million (71%) of the 57.7 million global deaths each year are attributed to NCDs. NCDs are often associated with older age groups, but evidence shows that more than 15 million of all deaths attributed to NCDs occur between the ages of 30 and 69 years. The total number of annual deaths of NCDs will further increase to 55 million by 2030 unless urgent preventive measures are taken.

Hong Kong is facing an increasing threat of NCDs, which is compounded by population ageing. In 2016, 25,771 registered deaths (approximately 55%) were attributed to NCDs. In addition, NCDs caused 104,600 potential years of life lost before 70 years of age.

WHO has identified four major behavioural risk factors - tobacco use, harmful use of alcohol, an unhealthy diet and physical inactivity - that contribute substantially to NCDs and can increase the risk of death. Most premature deaths from NCDs are preventable via lifestyle modification. Therefore, helping people adopting healthy lifestyle practices, such as having a balanced diet and engaging in regular physical activity, and quitting health-risk behaviours, such as smoking and harmful use of alcohol can help prevent NCDs and improve quality of life and the overall health of the population. However, many people are unmotivated or find it difficult to modify their risk behaviours, despite their awareness of the associated health hazards. Our previous studies showed that many smokers continued to smoke even after receiving a diagnosis of cancer, diabetes or cardiovascular disease. In addition, health risk behaviours co-occur in clusters and that many people exhibit multiple risk behaviours. A sample of 16,818 adults from the 1998 US National Health Interview Survey revealed that 52% had two or more risk behaviours, including physical inactivity, overweight, cigarette smoking and risky drinking. Our previous study in Hong Kong also found associations between smoking and physical inactivity, an unhealthy diet and alcohol consumption. People with multiple health risk behaviours are usually associated with a higher increased risk of NCDs and face more challenges in the adoption of a healthy lifestyle than those with a single health risk behaviour. A review of the literature reveals that most interventions have been developed and evaluated targeted at people with single risk behaviour rather than multiple risk behaviours. It is crucial therefore to develop and evaluate appropriate interventions that targeting people with multiple risk behaviours with the aim to help them quit health-risk behaviours and adopt a healthy lifestyle, either sequentially or concurrently. First, however, a thorough understanding of the clustering of multiple health risk behaviours and the factors associated with such behaviours are crucial before any appropriate interventions can be developed and evaluated. The aim of the study is to investigate the prevalence of multiple risk behaviours and their association with health consequences among people aged 30 years or above. The objectives of the study are:

  1. To investigate the clustering patterns of multiple health risk behaviours;
  2. To identify factors associated with multiple risk behaviours; and
  3. To find out the association between risk behaviours and non-communicable diseases.
Keywords
Risk behaviours, Health consequence, Non-communicable diseases
Medical subject headings
Noncommunicable Diseases

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Demographic data questionnaire

    Personal demographic characteristics (e.g. sex, age, educational attainment, marital status, occupation, household income)

    Measured: Baseline

  2. History of NCDs questionnaire

    NCDs characteristics

    Measured: Baseline

  3. Medical check-up questionnaire

    History of medical check-up

    Measured: Baseline

  4. Diet habits questionnaire

    Personal habits of diet (e.g. daily vegetable and fruit intake)

    Measured: Baseline

  5. Physical activity questionnaire

    Personal habits of diet and physical activity (e.g. daily physical activity amount and time)

    Measured: Baseline

  6. Unhealthy behaviors questionnaire

    Habits of risky behaviors (e.g. smoking/ alcohol habits, daily cigarette consumption)

    Measured: Baseline

  7. Knowledge and awareness of COVID-19 and NCDs questionnaire

    Knowledge and awareness of COVID-19 and NCDs (e.g. knowledge about relationship between smoking and COVID, relationship between NCDs and COVID, etc)

    Measured: Baseline

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted14 Jul 2021
  2. Study start21 Jun 2021
  3. Primary completion31 Aug 2021
  4. Study completion31 Aug 2021

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Cross-sectional
Enrolment
5,737 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04961073
Sponsor's protocol ID
NCD survey UW 21-440
Status last verified
Jul 2021
First submitted
19 Jun 2021
Last updated
13 Jan 2022
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: The relevant anonymized patient level data, full dataset, technical appendix, and statistical code are available on reasonable request. The approval from the Principal Investigator for the purpose of data use is required.

Questions about this trial

What is this clinical trial studying?

An observational study of Non-communicable Diseases, run by The University of Hong Kong at 1 site in Hong Kong.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 13 Jan 2022. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Hong Kong. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Demographic data questionnaire (time frame: Baseline). The study lists 7 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 13 Jan 2022.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in